4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-22-027681
CEO bought 100,000 shares at $0.34 ($33,540)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woods Lori A CEO | 2022-11-15 | Purchase | +100,000 | $0.34 | $33,540 | 1,147,038 | I: show line 1 in the form |
| Open-market purchases · 100,000 sh · avg $0.34 · $33,540 | |||||||
Loading xslF345X03/rdgdoc.xml…